Abstract
Medullary carcinoma (MC) of the breast is characterized by large anaplastic cells and infiltration by benign lymphocytes. Patients with this pattern of breast carcinoma are considered to have a better prognosis than those with other histological subtypes. We reviewed cases of primary breast carcinoma that were surgically resected between 1990 and 2004. Of these, 13 cases of medullary carcinoma of the breast with lymphocyte infiltration were reported. Tests for CD3, CD4, CD8, CD20, CD56, TIA-1, and granzyme B were performed on paraffin sections. We found that the MC contained very few NK cells, as assessed by their reactivity with the CD56 antibodies. However, MC had a significantly greater percentage of CD3, CD8, TIA-1, and granzyme B lymphocytes infiltrating the stroma of the tumor. Furthermore, more CD8-positive than CD4-positive T-cell lymphocytes were present within the tumor cell nests in MC, as opposed to the proportion in usual ductal carcinoma. The infiltrating cytotoxic/suppressor T cells in MC represent host resistance against cancer, and the high grading of the T-cell infiltration could explain, in part, a key mechanism controlling the good prognosis for this type of tumor and solve the pathological paradox of MC.
MeSH Terms
Breast Neoplasms/immunology,pathology
CD3 Complex/analysis
CD8 Antigens/analysis
Carcinoma, Medullary/immunology
Female
Humans
Immunohistochemistry
Immunophenotyping
Lymphocytes, Tumor-Infiltrating/immunology
Poly(A)-Binding Proteins
Proteins/analysis
RNA-Binding Proteins
T-Cell Intracellular Antigen-1
Chemicals
CD3 Complex
CD8 Antigens
Poly(A)-Binding Proteins
Proteins
RNA-Binding Proteins
T-Cell Intracellular Antigen-1
TIA1 protein, human
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Kuroda Hajime
Department of Pathology, Saitama Medical Center, Saitama Medical School 1981, Tsujido, Kamoda, 350-8550 Kawagoe, Saitama, Japan. hajime@saitama-med.ac.jp
Tamaru Jun-ichi
Sakamoto Goi
Ohnisi Kiyoshi
Itoyama Shinji
References (21)
21 references, click to expand
-
Nodal response in medullary carcinoma of the breast.
Am J Surg. 1976 Mar;131(3):263-6
PMID: 1259097
-
Antigenic phenotype of the lymphocytic component of medullary carcinoma of the breast.
Cancer. 1987 Jun 15;59(12):2037-41
PMID: 3032398
-
Immunophenotypic profile of tumor infiltrating lymphocytes in medullary carcinoma of the breast.
Eur J Gynaecol Oncol. 2002;23(5):433-6
PMID: 12440819
-
MAGE-1-specific precursor cytotoxic T-lymphocytes present among tumor-infiltrating lymphocytes from a patient with breast cancer: characterization and antigen-specific activation.
Cancer Res. 1996 Jan 1;56(1):16-20
PMID: 8548758
-
Cytotoxic phenotype of tumor infiltrating lymphocytes in medullary carcinoma of the breast.
Mod Pathol. 1999 Nov;12(11):1050-6
PMID: 10574602
-
Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer.
J Natl Cancer Inst. 1983 Sep;71(3):507-16
PMID: 6193308
-
Host resistance and survival in carcinoma of breast: a study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years.
Br Med J. 1970 Jul 25;3(5716):181-8
PMID: 5448777
-
The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators.
Surgery. 2003 Nov;134(5):827-34
PMID: 14639362
-
In vivo local expansion of clonal T cell subpopulations in renal cell carcinoma.
Cancer Res. 1995 Feb 1;55(3):685-90
PMID: 7834641
-
Growth and antigen recognition of tumor-infiltrating lymphocytes from human breast cancer.
J Interferon Cytokine Res. 1998 Jul;18(7):529-36
PMID: 9712369
-
High endothelial venule and immunocompetent cells in typical medullary carcinoma of the breast.
Virchows Arch A Pathol Anat Histopathol. 1992;420(3):253-61
PMID: 1553817
-
Identification of lymphocyte subpopulations in human breast cancer tissue and its significance: an immunoperoxidase study with anti-human T- and B-cell sera.
Cancer. 1982 Apr 1;49(7):1456-64
PMID: 6277465
-
Medullary carcinoma of the breast. Identification of lymphocyte subpopulations and their significance.
Mod Pathol. 1993 Nov;6(6):721-8
PMID: 8302815
-
Medullary breast carcinoma. A reevaluation of 95 cases of breast cancer with inflammatory stroma.
Cancer. 1988 Jun 15;61(12):2503-10
PMID: 2835145
-
An immune suppressive factor derived from esophageal squamous carcinoma induces apoptosis in normal and transformed cells of lymphoid lineage.
J Immunol. 1993 Nov 1;151(9):4847-56
PMID: 8409443
-
Typical medullary carcinoma of the breast: a clinical and pathological analysis of 52 cases.
J Surg Oncol. 1995 Oct;60(2):89-94
PMID: 7564387
-
Medullary carcinoma of the breast: a clinicopathologic study with appraisal of current diagnostic criteria.
Hum Pathol. 1988 Nov;19(11):1340-6
PMID: 2846422
-
Study of tumor infiltrating lymphocytes and transforming growth factor-beta as prognostic factors in breast carcinoma.
Int J Cancer. 1997 Oct 21;74(5):492-501
PMID: 9355970
-
Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up.
Cancer. 1977 Oct;40(4):1365-85
PMID: 907958
-
Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy.
J Natl Cancer Inst. 1996 Jan 17;88(2):100-8
PMID: 8537970
-
The relatively favorable prognosis of medullary carcinoma of the breast.
Cancer. 1949 Jul;2(4):635-42
PMID: 18144972